Troubled Tissue Regenix secure emergency funding

Regenerative medtech company Tissue Regenix has secured emergency cash to keep the lights on - but its longer-term survival still hangs on a larger capital raise.

The York-based company has obtained a $500,000 overdraft facility from its existing lender MidCap Financial - enough to cover November payroll and stave off an immediate collapse.

In a statement Tissue Regenix said the newly installed senior leadership team continues “to clarify the immediate fund... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...

Close